Indaptus Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Indaptus Therapeutics, Inc. on August 10, 2026. The filing primarily reports on the results of the Company's 2026 Annual Meeting of Stockholders held on August 10, 2026. Additionally, the filing references a press release dated August 13, 2026, containing financial results for the quarter ended June 30, 2026.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced Press Release (Exhibit 99.1), which is not included in the provided text.
Material Changes and Corporate Actions
The filing details the outcomes of three proposals voted upon at the Annual Meeting:
- Proposal 1 (Director Election): David Natan, Tim Ruan, and Dr. Johnny Fox Arrowsmith were elected as Class II directors for terms expiring in 2029.
- Proposal 2 (Auditor Ratification): The appointment of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified.
- Proposal 3 (Equity Plan): The Indaptus Therapeutics, Inc. 2026 Equity Incentive Plan was approved.
Voting Statistics: As of the June 12, 2026 Record Date, there were 113,242,324 shares outstanding. A total of 109,556,567 shares (approximately 96.75%) were present or represented by proxy at the meeting.
Guidance, Outlook, and Risks
The filing notes that the referenced Press Release contains forward-looking statements regarding the Company's expectations, plans, and prospects. However, the specific content of this guidance, along with any risks or contingencies, is not detailed in the text of this Form 8-K. The filing explicitly states that the information in the Press Release is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the specific financial results for the quarter ended June 30, 2026, by reviewing the Press Release (Exhibit 99.1) referenced in this filing.
- Confirm the terms and share limits of the newly approved 2026 Equity Incentive Plan.
- Note the high level of shareholder participation (96.75%) and the overwhelming support for the director elections and auditor ratification.
- Review the full text of the forward-looking statements in the August 13, 2026 Press Release to understand management's current outlook.